Back
Nicolet Bankshares 10K Form
Sell
44
NIC
Nicolet Bankshares
Last Price:
$118.24
Seasonality Move:
4.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-07 | 10Q | NIC/Nicolet Bankshares Quarterly |
2023-08-04 | 10Q | NIC/Nicolet Bankshares Quarterly |
2023-05-02 | 10Q | NIC/Nicolet Bankshares Quarterly |
2022-11-01 | 10Q | NIC/Nicolet Bankshares Quarterly |
2022-08-08 | 10Q | NIC/Nicolet Bankshares Quarterly |
2022-04-29 | 10Q | NIC/Nicolet Bankshares Quarterly |
Receive NIC News And Ratings
See the #1 stock for the next 7 days that we like better than NIC
NIC Financial Statistics
Sales & Book Value
Annual Sales: | $349.1M |
---|---|
Cash Flow: | $41.3M |
Price / Cash Flow: | 13.22 |
Annual Sales: | $78.11 |
Price / Book: | 1.5 |
Profitability
EPS (TTM): | 8.29000 |
---|---|
Net Income (TTM): | $128.9M |
Gross Margin: | $0 |
Return on Equity: | 11.38% |
Return on Assets: | 1.48% |
Nicolet Bankshares Earnings Forecast
Key Nicolet Bankshares Financial Ratios
-
The Gross Profit Margin over the past 9 years for NIC is 0.00%.
-
The Selling, General & Administrative Expenses for NIC have been equal to 34.59% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of NIC is 35.54% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 13 years.
Nicolet Bankshares Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Banks |
Sector: | Financials |
Current Symbol: | NIC |
Website: | nicoletbank.com |
Debt
Debt-to-Equity Ratio: | 0.13 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 14.66 |
---|---|
Forward P/E Ratio: | 13.26 |
NIC Technical Analysis vs Fundamental Analysis
Sell
44
Nicolet Bankshares (NIC)
is a Sell
Is Nicolet Bankshares a Buy or a Sell?
-
Nicolet Bankshares stock is rated a SellThe current Nicolet Bankshares [NIC] share price is $118.02. The Score for NIC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.